The latest price target for Jazz Pharmaceuticals (NASDAQ:JAZZ) was reported by HC Wainwright & Co. on March 10, 2025. The analyst firm set a price target for $217.00 expecting JAZZ to rise to ...

JAZZ stock opened at $138.81 on Thursday. The business has a 50 day moving average of $128.14 and a 200 day moving average of $120.03. The firm has a market cap of $8.43 billion, a PE ratio of 19. ...

BofA raised the firm’s price target on Jazz Pharmaceuticals (JAZZ) to $213 from $182 and keeps a Buy rating on the shares. The Phase 3 HERIZON-GEA-01 study is evaluating two zanidatamab-based ...

TD Cowen raised the firm’s price target on Jazz Pharmaceuticals (JAZZ) to $205 from $195 and keeps a Buy rating on the shares. The firm said Q4 revenue came in above consensus supported by solid ...

Sunday's NBA slate includes the Utah Jazz (15-52) hitting the road to square off against Anthony Edwards and the Minnesota Timberwolves (39-29) at Target Center. Game time is 7 p.m. ET ... Gannett may ...

That's part of the reason why Bleacher Report writer Eric Pincus listed Sheppard as a potential trade target for the Utah Jazz. "The Jazz are rebuilding and may prioritize the draft in 2025 and ...